File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: New targets and inhibitors of HBV replication to combat drug resistance

TitleNew targets and inhibitors of HBV replication to combat drug resistance
Authors
Cheng, YCYing, CXLeung, CHLi, Y
KeywordsHBV replication
Helioxanthin
Nucleos(t)ide analogues
Issue Date2005
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jcv
Citation
Journal Of Clinical Virology, 2005, v. 34 SUPPL. 1, p. S147-S150 How to Cite?
DOI: http://dx.doi.org/10.1016/S1386-6532(05)80026-5
AbstractAll the approved chemotherapeutic drugs for the treatment of HBV hepatitis are nucleoside analogs targeting on HBV DNA polymerase. Drugs targeting on other viral unique targets are needed. A new class of chemicals with novel action against HBV replication was discovered. A brief description of their mode of action is given. © 2005 Elsevier B.V. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/168000
ISSN
1386-6532
2021 Impact Factor: 14.481
2020 SCImago Journal Rankings: 1.430
ISI Accession Number ID
WOS:000208941500026
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorCheng, YCen_US
dc.contributor.authorYing, CXen_US
dc.contributor.authorLeung, CHen_US
dc.contributor.authorLi, Yen_US
dc.date.accessioned2012-10-08T03:13:57Z-
dc.date.available2012-10-08T03:13:57Z-
dc.date.issued2005en_US
dc.identifier.citationJournal Of Clinical Virology, 2005, v. 34 SUPPL. 1, p. S147-S150en_US
dc.identifier.issn1386-6532en_US
dc.identifier.urihttp://hdl.handle.net/10722/168000-
dc.description.abstractAll the approved chemotherapeutic drugs for the treatment of HBV hepatitis are nucleoside analogs targeting on HBV DNA polymerase. Drugs targeting on other viral unique targets are needed. A new class of chemicals with novel action against HBV replication was discovered. A brief description of their mode of action is given. © 2005 Elsevier B.V. All rights reserved.en_US
dc.languageengen_US
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jcven_US
dc.relation.ispartofJournal of Clinical Virologyen_US
dc.subjectHBV replication-
dc.subjectHelioxanthin-
dc.subjectNucleos(t)ide analogues-
dc.subject.meshAntiviral Agents - Chemical Synthesis - Pharmacologyen_US
dc.subject.meshDna, Viral - Biosynthesisen_US
dc.subject.meshDna-Directed Dna Polymerase - Antagonists & Inhibitorsen_US
dc.subject.meshDrug Designen_US
dc.subject.meshHepatitis B Virus - Drug Effects - Genetics - Metabolismen_US
dc.subject.meshLignansen_US
dc.subject.meshMicrobial Sensitivity Testsen_US
dc.subject.meshVirus Replication - Drug Effectsen_US
dc.subject.meshXanthines - Pharmacologyen_US
dc.titleNew targets and inhibitors of HBV replication to combat drug resistanceen_US
dc.typeArticleen_US
dc.identifier.emailLeung, CH:duncanl@hkucc.hku.hken_US
dc.identifier.authorityLeung, CH=rp00730en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/S1386-6532(05)80026-5en_US
dc.identifier.pmid16461217-
dc.identifier.scopuseid_2-s2.0-32044467143en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-32044467143&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume34en_US
dc.identifier.issueSUPPL. 1en_US
dc.identifier.spageS147en_US
dc.identifier.epageS150en_US
dc.identifier.isiWOS:000208941500026-
dc.publisher.placeNetherlandsen_US
dc.identifier.scopusauthoridCheng, YC=36041844200en_US
dc.identifier.scopusauthoridYing, CX=7101886519en_US
dc.identifier.scopusauthoridLeung, CH=7402612570en_US
dc.identifier.scopusauthoridLi, Y=26642976900en_US
dc.identifier.issnl1386-6532-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats